ribociclib
novartis
['natalee', '$nvs']
on media call, $nvs head of onc development jeff legos says it's very important that a consistent effect was seen in natalee. points out trial not powered for individual subgroups. and result not driven by one subgroup. confirms data will be filed with regs by year end. #asco23
Pharma and biotech reporter, found a home at Evaluate Vantage.